| |
| |
|
| Insider
Information: |
Blobel Friedhelm |
| Relationship: |
President, CEO, Direct... |
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sciclone Pharmaceuticals Inc |
SCLN |
President, CEO, Direct... |
2017-10-13 |
0 |
2007-11-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCLN |
Sciclone Pharmaceuticals ... |
President, CEO, Director |
• • – |
2017-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
387,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President, CEO, Director |
• • – |
2017-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
95,000 |
237,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President, CEO, Director |
• • – |
2017-10-13 |
4 |
D |
$11.18 |
$4,330,003 |
D/D |
(387,299) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-08-15 |
4 |
D |
$11.05 |
$230,636 |
D/D |
(20,872) |
141,337 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
162,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-30 |
4 |
AS |
$11.00 |
$385,484 |
D/D |
(35,044) |
122,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-30 |
4 |
OE |
$3.55 |
$136,082 |
D/D |
35,044 |
129,599 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-20 |
4 |
AS |
$10.90 |
$763,627 |
D/D |
(70,000) |
122,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-20 |
4 |
OE |
$3.55 |
$248,500 |
D/D |
70,000 |
162,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-12 |
4 |
D |
$10.75 |
$280,468 |
D/D |
(26,090) |
122,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
55,000 |
148,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-08 |
4 |
OE |
$3.55 |
$70,844 |
D/D |
19,956 |
113,255 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-08 |
4 |
AS |
$11.00 |
$219,608 |
D/D |
(19,956) |
93,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-07 |
4 |
AS |
$10.03 |
$197,524 |
D/D |
(19,700) |
93,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-07 |
4 |
OE |
$3.55 |
$69,935 |
D/D |
19,700 |
112,999 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-06 |
4 |
AS |
$10.00 |
$55,000 |
D/D |
(5,500) |
93,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-06 |
4 |
OE |
$3.55 |
$19,525 |
D/D |
5,500 |
98,799 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-02 |
4 |
OE |
$3.55 |
$17,040 |
D/D |
4,800 |
98,099 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-02 |
4 |
AS |
$10.00 |
$48,000 |
D/D |
(4,800) |
93,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-05-24 |
4 |
AS |
$9.36 |
$58,975 |
D/D |
(6,298) |
92,526 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-05-24 |
4 |
OE |
$3.55 |
$22,358 |
D/D |
6,298 |
98,824 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-05-23 |
4 |
OE |
$3.55 |
$53,839 |
D/D |
15,166 |
107,692 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-05-23 |
4 |
AS |
$9.31 |
$141,155 |
D/D |
(15,166) |
92,526 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-05-22 |
4 |
AS |
$9.44 |
$175,026 |
D/D |
(18,536) |
92,526 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-05-22 |
4 |
OE |
$3.55 |
$65,803 |
D/D |
18,536 |
111,062 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
